Skip to main content
Top

Endocrine Pathology

Issue 1/2022

Overview of the 2022 WHO Classification of Endocrine and Neuroendocrine Tumors

Content (10 Articles)

Overview of the 2022 WHO Classification of Pituitary Tumors

Sylvia L. Asa, Ozgur Mete, Arie Perry, Robert Y. Osamura

Overview of the 2022 WHO Classification of Thyroid Neoplasms

Zubair W. Baloch, Sylvia L. Asa, Justine A. Barletta, Ronald A. Ghossein, C. Christofer Juhlin, Chan Kwon Jung, Virginia A. LiVolsi, Mauro G. Papotti, Manuel Sobrinho-Simões, Giovanni Tallini, Ozgur Mete

Overview of the 2022 WHO Classification of Parathyroid Tumors

Lori A. Erickson, Ozgur Mete, C. Christofer Juhlin, Aurel Perren, Anthony J. Gill

Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas

Ozgur Mete, Sylvia L. Asa, Anthony J. Gill, Noriko Kimura, Ronald R. de Krijger, Arthur Tischler

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

Guido Rindi, Ozgur Mete, Silvia Uccella, Olca Basturk, Stefano La Rosa, Lodewijk A. A. Brosens, Shereen Ezzat, Wouter W. de Herder, David S. Klimstra, Mauro Papotti, Sylvia L. Asa

Overview of the 2022 WHO Classification of Adrenal Cortical Tumors

Ozgur Mete, Lori A. Erickson, C. Christofer Juhlin, Ronald R. de Krijger, Hironobu Sasano, Marco Volante, Mauro G. Papotti

Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes

Vania Nosé, Anthony Gill, José Manuel Cameselle Teijeiro, Aurel Perren, Lori Erickson

The Next Steps for Endocrine Pathology

Sylvia L. Asa, Lori A. Erickson, Ozgur Mete

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.